
Europe Microbial Identification Methods Market
No. of Pages: 127 | Report Code: BMIRE00029665 | Category: Life Sciences
No. of Pages: 127 | Report Code: BMIRE00029665 | Category: Life Sciences
The Europe microbial identification methods market was valued at US$ 1,232.92 million in 2022 and is expected to reach US$ 2,155.49 million by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.
Government Initiatives and Funding to Promote Microbial Identification Fuel the Europe Microbial Identification Methods Market
Government initiatives and funding promoting microbial identification are crucial pillars of public health, scientific research, and industrial development. These initiatives serve a wide range of purposes, from enhancing disease surveillance and response to supporting innovative research in microbiology. For instance, the Recommendation on intensifying EU activities to prevent Antimicrobial Resistance (AMR) in a One Health approach was accepted by the European Council (EC) on June 13, 2023. The European Parliament passed a resolution on EU action to address AMR on June 1, 2023. The EC adopted a proposal on April 26, 2023, as part of the pharmaceutical package, for a Council Recommendation on stepping up EU activities to address antimicrobial resistance in a One Health framework, together with a Commission Staff Working Document. Further, in 2023, the new European Roadmap on Antimicrobial Resistance (AMR), which assists nations in the WHO European Region in identifying, prioritizing, and putting into practice high-impact initiatives to combat AMR, has received the authorization of health ministers and delegates from WHO/Europe's 53 Member States. Overall, these initiatives and funding mechanisms play a pivotal role in safeguarding public health, advancing scientific knowledge, and driving economic growth by underpinning the microbial identification field.
Europe Microbial Identification Methods Market Overview
The growing prevalence of infectious diseases caused by microorganisms increases the need for microbial identification tests across Europe. Classifying microorganisms and bacteria is crucial for analyzing diseases for better treatment options. For instance, according to Food Safety News, Shiga toxin-producing E. coli (STEC) ranked as the fourth most prevalent foodborne illness in Europe in 2022. Ireland, Denmark, and Malta had the greatest country-specific notification rates, while Romania, Portugal, Greece, Slovakia, and Poland had the lowest rates. The country with the most infections was Germany (1,635), followed by Denmark (over 900) and Ireland (just under 900). In addition, 362 hemolytic uremic syndrome (HUS) cases were documented across practically all age categories, with the youngest age groups-0 to 4 and 5 to 14 years old-having the largest patient concentration. Furthermore, O26, O157, O80, and O145 were the major serogroups. Additionally, Yersinia infections climbed from 6,800 in 2020 to ~6,800 5,661 in 2019.
In addition, studying bacteria, parasites, fungi, and microbes is encouraging many investors in the pharmaceutical industry to invest in drug development projects. Aside from this, the necessity for microbiological identification methodologies to identify food spoilage contaminants is driven by the rising food safety concerns worldwide. These methods increase the shelf life of processed food goods while maintaining their authenticity and flavor. Furthermore, continuous advancements in microbiology and microbial identification equipment create a positive market outlook. For instance, in June 2023, inBiome, the Netherlands-based company, announced the launch of a new PCR-based molecular platform for diagnosing bacterial infections. The company claims the platform can be used in place of conventional culture and rivals' newer methods, such as sequencing, in terms of time, cost, and scope. Moreover, governments of various countries took many initiatives to prevent any further spread of infectious diseases, coupled with the growing expenditure on the healthcare industry, which is propelling the market growth.
Strategic insights for the Europe Microbial Identification Methods provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 1,232.92 Million |
Market Size by 2030 | US$ 2,155.49 Million |
Global CAGR (2022 - 2030) | 7.2% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By Method
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
|
The geographic scope of the Europe Microbial Identification Methods refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Accelerate Diagnostics Inc, Avantor Inc, Becton Dickinson and Co, bioMérieux SA, Bruker Corp, Danaher Corp, Merck KGaA, Molzym GmbH & Co KG, Shimadzu Corp, Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe microbial identification methods market.
1. Accelerate Diagnostics Inc
2. Avantor Inc
3. Becton Dickinson and Co
4. bioMérieux SA
5. Bruker Corp
6. Danaher Corp
7. Merck KGaA
8. Molzym GmbH & Co KG
9. Shimadzu Corp
10. Thermo Fisher Scientific Inc
11. Biolog Inc
The Europe Microbial Identification Methods Market is valued at US$ 1,232.92 Million in 2022, it is projected to reach US$ 2,155.49 Million by 2030.
As per our report Europe Microbial Identification Methods Market, the market size is valued at US$ 1,232.92 Million in 2022, projecting it to reach US$ 2,155.49 Million by 2030. This translates to a CAGR of approximately 7.2% during the forecast period.
The Europe Microbial Identification Methods Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Microbial Identification Methods Market report:
The Europe Microbial Identification Methods Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Microbial Identification Methods Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Microbial Identification Methods Market value chain can benefit from the information contained in a comprehensive market report.